Ganesh Balasubramanian, Rajakumar Thangarasu, Malathi Mathiyazhakan, Manikandan Natesan, Nagaraj Jaganathasamy, Santhakumar Aridoss, Elangovan Arumugam, Malik Yashpal Singh
ICMR-National Institute of Epidemiology (ICMR-NIE), R-127, Second Main Road, TNHB, Ayapakkam, Chennai, 600 077, Tamil Nadu, India.
Indian Veterinary Research Institute (IVRI), Izatnagar, 243 122, Bareilly, Uttar Pradesh, India.
Clin Epidemiol Glob Health. 2021 Apr-Jun;10:100694. doi: 10.1016/j.cegh.2020.100694. Epub 2021 Jan 14.
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative etiology of 'Corona Virus Disease-2019' (COVID-19); formerly referred as 'novel-Coronavirus-2019'. It was originated in Wuhan city, Hubei province, China in early December 2019. The World Health Organization (WHO) declared it as 'Public Health Emergency of International Concern' due to their rapid transmission and causing public and health-care-related casualties worldwide. This review provides an updated overview of COVID-19 (SARS-CoV-2), in comparison with the etiologies of the same group viz. SARS and MERS and also its future perspectives for planning appropriate strategies for prevention, control and treatment modalities to avert similar catastrophe in near future.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是“2019冠状病毒病”(COVID-19)的病原体;以前称为“2019新型冠状病毒”。它于2019年12月初在中国湖北省武汉市出现。世界卫生组织(WHO)因其在全球迅速传播并造成公众和医疗相关伤亡,宣布其为“国际关注的突发公共卫生事件”。本综述提供了COVID-19(SARS-CoV-2)的最新概述,并与同一类病原体即SARS和MERS进行了比较,还探讨了其未来前景,以便制定适当的预防、控制和治疗策略,避免在不久的将来发生类似灾难。